isabelobrien, Author at European Medical Journal - Page 17 of 65

Janice Walshe

Onc Now: Episode 16: Fertility, Funding, and the Future of Oncology

Janice Walshe, Consultant Medical Oncologist at St Vincent’s University Hospital in Dublin, explores access to innovation in cancer care, the challenges of fertility preservation, and the future of oncology in Ireland.

ViiV, Roche and Gilead lead pharma patient group rankings

ViiV leads the 2024/25 pharma company reputation rankings, with the PatientView report also finding ways to improve.

An illustration of a four leaf clover

Ireland launches landmark childhood cancer genomics study

Ireland has launched its first national clinical genomics study in paediatric oncology.

John Riches

Hema Now: Episode 15: Understanding B cell Metabolism in Lymphoma

John Riches, Clinical Reader in Cancer Immunometabolism, Barts Cancer Institute; Honorary Consultant Haemato-oncologist, Barts Health NHS Trust, London, UK, discusses how metabolism could conquer lymphoma.

Handshake on blue background

Boehringer and Tessellate partner to tackle tough cancer targets

Boehringer Ingelheim and Tessellate Bio form a €500m partnership to develop precision therapies.

5 minutes with... Dr Tami Nussbaum, Takeda

Dr Tami Nussbaum, shares why she left medicine for pharma, the challenges of rare disease and how she avoids burnout.

50 states of the US

US pharma tariffs: What they mean for drug prices

US drug tariffs may not hit branded prices hard, but generics and supply chains face disruption. Here’s what pharma leaders need to know.

Alexander Spira podcast

Onc Now: Episode 15: Rewriting the Rules of Lung Cancer Therapy

Alexander Spira, Director of the Thoracic and Phase I Program at Virginia Cancer Specialists, explores breakthroughs in lung and colorectal cancer treatment.

5 minutes with... Kate Lenik, Chiesi

Kate Lenik shares her journey into HR, the evolving pharma workplace, and the secrets behind Chiesi’s award-winning culture.

Scientists crack the code for keeping lab-grown tissue alive

FluidForm Bio’s 3D bioprinting tech keeps lab-grown cells alive five times deeper using vascular-like gelatin scaffolds.